DISCLOSURE OF CONFLICTS OF INTEREST

AASLD requires all individuals who are in a position to control the content of an educational activity to disclose all relevant financial relationships with any commercial entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. Disclosures are collected prior to the start of the educational activity. Any potential conflicts of interest that exist are resolved prior to implementation of the activity. All disclosures are made available and communicated to the leaner prior the activity beginning.

The organizers and faculty have reported the following disclosures:

Faculty

Manal F. Abdelmalek, MD, MPH, FAASLD
Grants/Research Support: Intercept, Gilead, Allergan, Genfit, BMS, NGM, Novo Nordisk, Madrigal, Target NASH, Progenity, Boerhinger-Ingelheim. Viking, Poxel, Durect, Inventiva, Celgene, Hanmi, Medimmune, Galactin, Galacto, Genentech
Scientific Consulting: NGM Pharmaceuticals, BMS Pharma, Hamni, Novo-Nordisk, Madrigal, 89Bio, Almentiv, SonicIncytes, Theratechnologies
Speakers Bureau: Clinical Care Options, Terra Firma, Fishawack Inc.

Juan G. Abraldes, MD
Scientific Consulting: Genfit, Lupin
Grants/Research Support: Gilead

Veeral H. Ajmera, MD
Other: Uncompensated advisory role Ocelot Bio

Naim Alkhouri, MD
Speakers Bureau: Gilead Sciences, Abbvie, Abbott, Merck
Scientific Consulting: Intercept, Pfizer, Gilead, Echosens, Fibronostics, LG Chem, Novo Nordisk, 89Bio, Akero
Grants/Research Support: Akero, Allergan, Gilead, Intercept, Madrigal, NGM, Pfizer, Zydus

Frank A. Anania, MD, FAASLD, FACP
Grants/Research Support: Federal government

Quentin M. Anstee, MBBS, PhD, FRCP
Scientific Consulting: 89Bio, Abbott Laboratories, Acuitas Medical, Allergan/Tobira, Altimmune, AstraZeneca, Axcella, Blade, BMS, BNN Cardio, Celgene, Cirius, CymaBay, EcoR1, E3Bio, Eli Lilly & Company Ltd., Galmed, Genentech, Genfit SA, Gilead, Grunthal, HistoIndex, Indalo, Imperial Innovations, Intercept Pharma Europe Ltd., Inventiva, IQVIA, Janssen, Madrigal, MedImmune, Metacrine, NewGene, NGMBio, North Sea Therapeutics, Novartis, Novo Nordisk A/S, PathAI, Pfizer Ltd., Poxel, ProSciento, Raptor Pharma, Servier, Terns, Viking Therapeutics.
Grants/Research Support: Abbvie, Allergan/Tobira, AstraZeneca, GlaxoSmithKline, Glympse Bio, Novartis Pharma AG, Pfizer Ltd., Vertex.

Cynthia A. Behling, MD, PhD
Other: I am a central reviewer for pathology slides for Covance Labs and ICON.

Naga P. Chalasani, MD, FAASLD
Scientific Consulting: Foresite labs, Axcella, Galectin, Zydus in last 12 months
Grant/Research Support: DSM,Galectin, Exact Sciences, Clinical Care Options, Terra Firma, Fishawack Inc.

Michael R. Charlton, MD, FRCP 
Grants/Research Support: Gilead Sciences, Novartis, Northsea, Madrigal, Lipocine, Bristol Myers Squib, Sagimet, Amra, Hepion, Pfizer
Scientific Consulting: Gilead Sciences, Lipocine, Intercept, Celgene/Bristol-Myers, Siemens, Histoindex, Prosciento, Cymabay, Fractyl Labs, Mallinkrodt, Arbutus, Blade, Corcept, Echosens, Fujifilm, Pfizer, Amra,Terns, Metacrine, PRA, Pfizer, Arbutus, Eiger, VIR Bio

Raymond T. Chung, MD, FAASLD
Grants/Research Support: Abbvie, Merck, Boehringer Ingelheim, Gilead, Janssen, BMS, Roche, Synlogic, Kaleido, DSMB Alnylam (Uncompensated)

Summer Collier, MSN, FNP-BC, AAHIVS
Nothing to disclose

Kathleen E. Corey, MD, MPH, MMSc
Grants/Research Support: BMS
Scientific Consulting: Gilead, Novo Nordisk

Anna Mae Diehl, MD, FAASLD
Consulting: Allergan, Alderya Therapeutics, Merk, Filcitrine, SunBioPharma, Casma, RAPT Therapeutics, Generon, DILIsym Services
Grants/Research Support: Boerhinger-Ingelheim, Madrigal, NovoNordisk, Novartis, Celgene, Poxel, Enyo, Target NASH, Genfit, Intercept, Galmed, AstraZeneca, Excella Health, Hanmi, NGM, Allergan

Stephen A. Harrison, MD, FAASLD
Scientific Consulting: B. Riley, Roth Capital, VenBio, Alentis, North Sea, Arrowhead, Canphite, Enyo, Fortress Bio, Gilead, Kowa
Grants/Research Support: NGM Bio, Echosens, Cirius Therapeutics, HistoIndex, Madrigal, Genfit, Intercept, Civi Biopharma, Cymabay, Novo Nordisk, Viking, Akero, Hightide, Metacrine, Terns, Blade, Sagimet, Hepion, Liminal, Galectin, Medpace, Altimmune, Axcella, Foresite Labs, Poxel, Ridgeline Therapeutics, Fibronostics, Galectin, Hepion, Genfit, Madrigal, Gilead, Cymabay, Intercept, Novo Nordisk, Cirius, Hightide, Enyo, Northsea, Genentech, Viking, Novartis, Sagimet

David Kleiner, MD, PhD
Nothing to disclose 

Michelle Long, MD, MSc
Grants/Research Support: Echosens, Gilead Sciences
Scientific Consulting: Ionis Pharmaceutics

Rohit Loomba, MD, FAASLD
Grants/Research Support: Allergan, Boehringer-Ingelheim, Bristol-Myers Squibb, Eli Lilly and Company, Galectin Therapeutics, Galmed Pharmaceuticals, GE, Genfit,
Gilead, Intercept, Janssen, Madrigal Pharmaceuticals, Merck, NGM Biopharmaceuticals, Pfizer, and Siemens
Scientific Consulting: Intercept, Ionis, Janssen Inc., Merck, NGM Biopharmaceuticals, Novo Nordisk, Pfizer, Madrigal, Terns, Theratechnologies, Glympse bio, Metacrine, Viking, Ini Pharma, Sagimat Biosciences

Mary E. McCarthy Rinella, MD, FAASLD
Scientific Consulting: TREAT consortium, Novartis, Gilead
Grants/Research Support: NGM

Marialena Mouzaki, MD
Nothing to disclose 

Mazen Noureddin, MD
Grants/Research Support: Allergan, BMS, Gilead, Galmed, Galectin, Genfit, Conatus, Enanta, Madrigal, Novartis, Shire, Viking and Zydus
Stock/Stock Options: Anaetos and Rivus Pharma
Scientific Consulting: 89BIO, Gilead, Intercept, Novo Nordisk, EchoSens, Terns

Vlad Ratziu, MD
Advisory Committees and/or Review Panels: GalMed, Boehringer-Ingelheim, Intercept, Genfit, Enanta, Gilead, NGM, Allergan, Madrigal, Novo-Nordisk, 89 Bio, Prosciento

Lisa M. Richards, MSN, FNP, AF-AASLD
Scientific Consulting: Intercept

Arun J. Sanyal, MD, FAASLD
Employment: Sanyal Bio
Stock/Stock Options: Exhalenz, Akarna, GenFit, Hemoshear, Durect, Idalno, Tizana
Royalties: Elsevier, Uptodate
Scientific Consulting: Conatus, Gilead, Echosens-Sandhill, Boehringer Ingelhiem, Merck, Hemoshear, Lilly, Ardelyx, Terns, ENYO, Birdrock, ALBIREO, SANOFI, JANNSEN, TAKEDA, ZYDUS, AMRA, POXEL, SERVIER, SECOND GENOME, Novo Nordisk, Novartis, Nimbus, malinckrodt, Pfizer, Salix
Grants/Research Support: Conatus, Gilead, malinckrodt, Salix, Novartis, Galectin, Bristol Myers, Sequana

Suzanne R. Sharpton, MD, MAS
Nothing to disclose 

Brent A. Tetri, MD, FAASLD
Scientific Consulting: Allergan, Alnylam, Arrowhead,  Axcella, Boehringer Ingelheim, BMS, Durect, Enanta, Ferring, Fortress, Gelesis, Genfit, Gilead, HepGene, High Tide, HistoIndex, Intercept, Lipocine, Madrigal, Medimmune, Merck, Mundipharma, NGM, pH-Pharma, Siemens
Grants/Research Support: Allergan, BMS, Cirius, Enanta, Genfit, Gilead, Intercept, Madrigal, NGM

Monica A. Tincopa, MD, MSc
Nothing to disclose 

Elizabeth C. Verna, MD, MS
Grant/Research Support: Salix Pharmaceuticals 

Vincent Wong, MD
Scientific Consulting: 3V-BIO, AbbVie, Allergan, Boehringer Ingelheim, Center for Outcomes Research in Liver Diseases, Echosens, Gilead Sciences, Hanmi Pharmaceutical, Intercept, Inventiva, Merck, Novartis, Novo Nordisk, Perspectum Diagnostics, Pfizer, ProSciento, Sagimet Biosciences, TARGET PharmaSolutions, Terns
Speakers' Bureau: Abbott, AbbVie, Bristol-Myers Squibb, Echosens, Gilead Sciences

Zobair M. Younossi, MD, MPH, FAASLD
Scientific Consulting: Gilead, Intercept, BMS, Abbvie, GSK
Advisory Committees and/or Review Panels: Gilead, BMS, Intercept, Abbvie and GSK

Basic Research Committee

Bernd Schnabl, MD, FAASLD
Grants/Research Support: CymaBay Therapeutics, Synlogic Operating Company, BiomX, Axial Biotherapeutics; Scientific Consultant/Advisor to Industry or Commercial Enterprise, including Development of Educational Presentations: Intercept Pharmacuticals, Ferring Pharmaceuticals, Patara Pharamaceuticals

Laurie D. DeLeve, MD, PhD, FAASLD
Scientific Consultant/Advisor to Industry or Commercial Enterprise, including Development of Educational Presentations: Daiich Sankyo;  Intellectual Property Rights (Patents, Royalties, Licensing fees): COMPOSITIONS AND METHODS FOR AMELIORATING TISSUE INJURY, ENHANCING LIVER REGENERATION AND STEM CELL THERAPIES, 2017-230-01 US no. 62/544,589 End-organ selective MMP inhibition enhances bone marrow progenitor cell recruitment Southern California GBC ref.: 6177.132445PCT 

Muyiwa Awoniyi, MD, PhD
Nothing to disclose.

Olivier Barbier, PhD, FAASLD
Grants/Research Support: Canadian Institute for Health Research (public, Canada);

Lily Dara, MD
Nothing to disclose.

Ariel E. Feldstein, MD
Scientific Consultant/Advisor to Industry or Commercial Enterprise, including Development of Educational Presentations: Gilead Merck ; Oppilan Pharma ; GSK

Sandy Feng, MD, PhD
Grants/Research Support: Novartis, Quark
Leadership in related society: Board, Committee, Journal: Juno Therapeutics, Inc., America Journal of Transplantation, Immune Tolderance Network, OPTN/UNOS, The New England Journal of Medicine
Stock/Stock Options: Amgen, Johnson & Johnson, Stryker, Abbott, Charles River Labs, Eli Lily, Express Scripts, Glaxo-Smith Klein, Medco, Merck, Pfizer, Hospira

Mercedes Fernandez, PhD
Nothing to disclose.

Heather L. Francis, PhD, FAASLD
Nothing to disclose.

Rohit Kohli, MBBS, MS, FAASLD
Speaker's Bureau: Alexion Pharmaceuticals
Data Safety Monitoring Board for Industry or Commercial Enterprise: Takeda Pharmaceuticals
Grants/Research Support: Epigen Pharma, Vision Pharmaceuticals
Leadership in related society: NASPGHAN Foundation Board

T. Jake Liang, MD, FAASLD
Nothing to disclose.

Pranoti Mandrekar, PhD, FAASLD
Nothing to disclose.

Laura E. Nagy, PhD, FAASLD
Nothing to disclose.

Kari Nejak-Bowen, MBA, PhD
Nothing to disclose.

Silvia M. Vilarinho, MD, PhD
Nothing to disclose.

Clinical Research Committee

Ulrich Beuers, MD
Nothing to disclose.

Jasmohan S. Bajaj, MD, FAASLD
Grants/Research Support: Valeant, Grifols
Leadership in related society: Board, Committee, Journal: ACG: American Journal of Gastroenterology AE, AGA: Microbiome Scientific Advisory Board
Scientific Consultant/Advisor to Industry or Commercial Enterprise, including Development of Educational Presentations: Valeant, Norgine

Therese Bittermann, MD
Nothing to disclose

Edward Doo, MD
Nothing to disclose

Andrea A. Gossard, APRN, CNP
Nothing to disclose

Gene Y. Im, MD
Nothing to disclose

Mariana Lazo, MD, PhD
Nothing to disclose

Rohit Loomba, MD
Scientific Consultant/Advisor to Industry or Commercial Enterprise, including Development of Educational Presentations: Glympse bio, Metacrine, Viking, Ini Pharma Ionis, Intercept, Ionis, Janssen Inc., Merck, NGM Biopharmaceuticals, Novo Nordisk, Pfizer, Madrigagal
Grants/Research Support: Allergan, Boehringer-Ingelheim, Bristol-Myers Squibb, Eli Lilly and Company, Galectin Therapeutics, Galmed Pharmaceuticals, GE, Genfit, Gilead, Intercept, Janssen, Madrigal Pharmaceuticals, Merck, NGM Disclosure updated: July 27, 2020 Biopharmaceuticals, Pfizer, and Siemens

Arpan Arun Patel, MD
Grants/Research Support: Gilead, Shire

Shari S. Rogal, MD, MPH
Nothing to disclose

Emily J. Rothbaum Perito, MD
Nothing to disclose

Shimul A. Shah, MD
Nothing to disclose

Tracey G. Simon, MD
Nothing to disclose

James E. Squires, MD, MS
Nothing to disclose

Grace L. Su, MD, FAASLD
Leadership in related society:  Member, Clinical Guidelines Committee, AGA; Company Employee, Officer, Director : My husband and son have equity interest in Applied Morphomics and Prenovo.

Monica A. Tincopa, MD MSc
Nothing to disclose

Kymberly Watt, MD
Expert testimony: Intercept - site- PI, Gilead - site PI, co-I, Conatus - site co-I, Novartis - previous site PI, co author study subanalysis, Pfizer- site co-I, all multicenter study related
Stock/Stock Options: BMS; Arbutus; Madrigal; Viking

AASLD Staff 

Matthew D’Uva
Nothing to disclose

Stephanie Grimsby
Nothing to disclose

Melissa Morrison
Nothing to disclose

Melanie Stanton
Nothing to disclose

Suzanne Thibeault
Nothing to disclose

Brittany Tyrrell
Nothing to disclose

Anne Wrobel
Nothing to disclose